Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 4312-4316, October 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, B. E.
Right arrow Articles by Gutierrez, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, B. E.
Right arrow Articles by Gutierrez, P. L.

Effects of pH and Temperature on the Stability and Decomposition of N,N'N''-Triethylenethiophosphoramide in Urine and Buffer1

Brian E. Cohen, Merrill J. Egorin, M. S. Balachandran Nayar and Peter L. Gutierrez2

Division of Developmental Therapeutics, University of Maryland Cancer Center, Baltimore, Maryland 21201

N,N',N''-Triethylenethiophosphoramide (thiotepa) was dissolved at 100 µg/ml in urine or in 0.1 M sodium acetate buffer and incubated at 37° or 22°. After 0, 15, 30, 60, 90, and 120 min of incubation, 0.1-ml samples were extracted into ethyl acetate and analyzed by gas-liquid chromatography (1.8-m x 2-mm column packed with 3% OV225 on 100/120 Supelcoport; oven at 180°; injection port and nitrogen-phorphorus detector at 230°). Thiotepa was more stable at 22° than at 37° and at pH 6 to 7 than at pH 4 to 5.5. After 2 hr of incubation at 37°, thiotepa concentrations decreased by 40% at pH 5.0 but only 10% at pH 6 or 7. Although thiotepa concentrations declined as described above, alkylating activity, as assessed by p-nitrobenzyl pyridine reactivity, was stable at all temperatures and pHs tested. Partition coefficients of thiotepa degradation products into toluene, ethyl acetate, diethyl ether, and hexane were determined after 0 and 120 min of incubation in urine at pH 4.0. The extractability of alkylating activity into these organic solvents decreased dramatically after 120 min. Thiotepa degradation products were extracted from urine at pH 4.0 after 0, 30, 60, and 120 min incubation at 37° and were separated by thin-layer chromatography. In addition to thiotepa (Rf 0.15), 3 degradation products possessing p-nitrobenzyl pyridine alkylating activity (Rf 0.35, 0.52, and 0.60) were observed during the course of incubation. The structures of the materials with Rf 0.35 and 0.52 were identified by mass spectrometry and indicated that thiotepa degradation occurs by successive addition of HCl molecules with opening of the aziridine rings and conversion to 2-chloroethyl moieties.

1 This work was supported by grants from Lederle Laboratories and the Bressler Foundation.

2 To whom requests for reprints should be addressed.

Received 1/25/84. Accepted 6/25/84.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. J. van Maanen, I. M. Tijhof, J. M. A. Damen, C. Versluis, J. J. K. van den Bosch, A. J. R. Heck, S. Rodenhuis, and J. H. Beijnen
A Search for New Metabolites of N,N',N''-Triethylenethiophosphoramide
Cancer Res., September 1, 1999; 59(18): 4720 - 4724.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.